What is Beijing Bohui Innovation Biotechnology Group Co., Ltd.'s (300318.SZ) StockRank?

MoatMap's StockRank for Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) is 12/100, with a Strong Sell signal. This is a composite score combining Quality (34), Value (36), and Momentum (28) factor ranks across MoatMap's 19,000+ stock universe.

Does Beijing Bohui Innovation Biotechnology Group Co., Ltd. have an economic moat?

Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Beijing Bohui Innovation Biotechnology Group Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Beijing Bohui Innovation Biotechnology Group Co., Ltd. in?

Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300318.SZ

STRONG SELLREMOVE

Beijing Bohui Innovation Biotechnology Group Co., Ltd. · Healthcare · China · $613M · Avg Vol: $5M/d

StockRank

P/E (TTM)

—

ROE

-8.0%

D/E

0.4x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Beijing Bohui Innovation is a healthcare diagnostics and blood products company. It lacks the scale, regulatory moat, and high ROIC of leading global CDMOs or diagnostics players, making it a poor fit for our concentrated portfolio.

COMPANY DESCRIPTION

Beijing Bohui Innovation Biotechnology Group Co., Ltd. develops and manufactures in vitro diagnostic (IVD) systems and blood products, specializing in trace element detection and molecular diagnostics. The company is the undisputed market leader in China's pediatric trace element clinical testing segment, utilizing its proprietary atomic absorption spectrometry technology. Its dual-focus business model, combining high-margin diagnostic instruments with blood product manufacturing, provides diversified growth streams.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	118M	155M	126M	122M	1.2%
EPS	-0.01	-0.00	0.00	-0.02	—
Shares	817M	817M	817M	817M	0.0%
Debt	117M	119M	156M	167M	12.6%
Equity	206M	202M	204M	190M	-2.7%
Op CF	6M	20M	-6M	-20M	236.5%
Inv CF	-21M	-25M	-28M	-19M	—
Fin CF	26M	1M	29M	46M	—

PRICE (1M)-18.4%

SMA 50SMA 200

$0.68

RSI (14)

24.5

52W High

$1.28

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

-5.0%39.2

ROE

-8.0%36.7

GP/Assets

6.4%20.7

Op. Margin

1.3%47.1

FCF/Assets

8.8%83.8

Piotroski

—0.8

Int. Cover

-4.1x31.5

D/E Ratio

0.43x34.9

Current Ratio

0.94x8.5

Value

P/E (TTM)

—N/A

EV/EBITDA

122.7x2.4

P/FCF

74.5x83.3

P/B

2.9x40.9

P/S

4.6x44.0

Div Yield

—N/A

Momentum

52W High %

53%27.6

RS 6M

-42%27.7

SMA 50/200

0.89x31.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$613M

P/E (Forward)

—

Gross Margin

33.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300318.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300318.SZ	Beijing Bohui Innovation Biotechnology Group Co., Ltd.(you)	$613M	12	STRONG SELL
688136.SS	Kexing Biopharm Co., Ltd.	$626M	12	STRONG SELL
300149.SZ	ChemPartner PharmaTech Co.,Ltd.	$642M	15	STRONG SELL
688302.SS	Hinova Pharmaceuticals Inc.	$582M	14	STRONG SELL
2105.HK	Laekna, Inc.	$666M	15	STRONG SELL
1167.HK	Jacobio Pharmaceuticals Group Co., Ltd.	$490M	12	STRONG SELL
2591.HK	Guangzhou Innogen Pharmaceutical Group Co., Ltd	$648M	7	STRONG SELL
6955.HK	Shandong Boan Biotechnology Co., Ltd.	$455M	9	STRONG SELL
688639.SS	Anhui Huaheng Biotechnology Co., Ltd.	$868M	17	STRONG SELL
2256.HK	Abbisko Cayman Limited	$826M	18	STRONG SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) — Stock Score Summary

Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) has a MoatMap StockRank of 12/100 based on Quality (34/100), Value (36/100), and Momentum (28/100) factor scores. The current signal is STRONG SELL. Beijing Bohui Innovation is a healthcare diagnostics and blood products company. It lacks the scale, regulatory moat, and high ROIC of leading global CDMOs or diagnostics players, making it a poor fit for our concentrated portfolio.

Key Financial Metrics

Price	$0.68
Market Cap	$613M
Price/Book	2.91
Return on Equity	-8.0%
Return on Invested Capital	-5.0%
Debt/Equity	42.76
Gross Margin	33.7%
Operating Margin	1.3%
Revenue Growth	-5.8%
Free Cash Flow	$8M

Beijing Bohui Innovation Biotechnology Group Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing Bohui Innovation Biotechnology Group Co., Ltd.’s (300318.SZ) StockRank?: MoatMap’s StockRank for Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) is 12/100, with a Strong Sell signal. It is a composite of Quality (34), Value (36), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does Beijing Bohui Innovation Biotechnology Group Co., Ltd. have an economic moat?: Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing Bohui Innovation Biotechnology Group Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing Bohui Innovation Biotechnology Group Co., Ltd. in?: Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).